Showing results (1751-1760 of 5,064) with videos related to

Sort By:
Pageof 507
Multiple Sclerosis and Related Disorders|March 23, 2021
Myelin oligodendrocyte glycoprotein antibody-associated disorders coexisting with ankylosing spondylitis: Potential association between demyelination and tumor necrosis factor inhibitorsWenjng Luo, Rui Li, Yanyu Chang, et al.
Multiple Sclerosis and Related Disorders|March 12, 2021
First report of HHV-8 viral load and seroprevalence of major blood-borne viruses in Iranian patients with systemic sclerosisAva Hashempour, Javad Moayedi, Zahra Musavi, et al.
Multiple Sclerosis and Related Disorders|March 7, 2021
A randomized pilot trial of oral prednisone taper vs placebo following iv methylprednisolone for multiple sclerosis relapses: Effects on adrenal function and clinical efficacyChiara Zecca, Giulio Disanto, Gianna C Riccitelli, et al.
Multiple Sclerosis and Related Disorders|January 29, 2021
Para-infectious anti-GD2/GD3 IgM myelitis during the Covid-19 pandemic: Case report and literature reviewLuis Alberto Rodríguez de Antonio, Inés González-Suárez, Inés Fernández-Barriuso, et al.
Multiple Sclerosis and Related Disorders|December 16, 2021
Discontinuation of disease modifying therapies is associated with disability progression regardless of prior stable disease and ageDejan Jakimovski, Katelyn S Kavak, Caila B Vaughn, et al.
Multiple Sclerosis and Related Disorders|December 16, 2021
Blood lactate concentrations during rest and exercise in people with Multiple Sclerosis: A systematic review and meta-analysisLuke Cerexhe, Chris Easton, Eilidh Macdonald, et al.
Multiple Sclerosis and Related Disorders|December 17, 2021
Implementation study of the 2021 German guideline for diagnosis and treatment of multiple sclerosisC Mokry, C Warnke, K Gehring, et al.
Multiple Sclerosis and Related Disorders|December 19, 2021
A much needed metric: Defining reliable and statistically meaningful change of the oral version Symbol Digit Modalities Test (SDMT)L B Strober, J M Bruce, P A Arnett, et al.
Multiple Sclerosis and Related Disorders|January 15, 2022
Pediatric anti-N-methyl-D-aspartate receptor encephalitis with MOG-Ab co-existence: Relapse propensity and treatabilityZhang Weihua, Gong Shuai, Ren Changhong, et al.
Multiple Sclerosis and Related Disorders|January 16, 2022
Comparing diagnostic criteria for the diagnosis of neurocognitive disorders in multiple sclerosisLaura M Hancock, Bruce Hermann, Menno M Schoonheim, et al.
Pageof 507